Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort

Autor: Mahesh, Sarki, Chang, Ming, Souria, Aissaoui, Nicole, Bürki, Maria, Caiata-Zufferey, Tobias Ephraim, Erlanger, Rossella, Graffeo-Galbiati, Karl, Heinimann, Viola, Heinzelmann-Schwarz, Christian, Monnerat, Nicole, Probst-Hensch, Manuela, Rabaglio, Ursina, Zürrer-Härdi, Pierre Olivier, Chappuis, Maria C, Katapodi, On Behalf Of The Cascade Consortium

Publikováno v: Cancers; Volume 14; Issue 7; Pages: 1636
Sarki, Mahesh; Ming, Chang; Aissaoui, Souria; Bürki, Nicole; Caiata-Zufferey, Maria; Erlanger, Tobias Ephraim; Graffeo-Galbiati, Rossella; Heinimann, Karl; Heinzelmann-Schwarz, Viola; Monnerat, Christian; Probst-Hensch, Nicole; Rabaglio, Manuela; Zürrer-Härdi, Ursina; Chappuis, Pierre Olivier; Katapodi, Maria C (2022). Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort. Cancers, 14(7) MDPI AG 10.3390/cancers14071636

Cascade screening for Tier 1 cancer genetic conditions is a significant public health intervention because it identifies untested relatives of individuals known to carry pathogenic variants associated with hereditary breast and ovarian cancer (HBOC)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0caa0c80158f6b0d9318a6c1160d9903